期刊文献+

基于CRISPR/Cas9技术的重组病毒HSV-2-EGFP的构建

Construction of recombinant herpes simplex virus 2 expressing enhanced green fluorescent protein using CRISPR/Cas9
原文传递
导出
摘要 目的利用CRISPR/Cas9(clustered,regularly interspaced,short palindromic repeat/CRISPR-associated nuclease 9)技术构建携带增强型绿色荧光蛋白(enhanced green fluorescent protein,EGFP)基因的单纯疱疹病毒2型(herpes simplex virus 2,HSV-2)。方法利用CRISPR/Cas9技术对外源基因EGFP插入HSV-2基因组的策略进行探索,设计如下4种插入策略:(1)经典的同源重组修复模式,即环状双侧同源臂供体介导的基因敲入;(2)线性化单侧同源臂供体介导的基因敲入;(3)同源性非依赖介导的基因敲入;(4)利用稳表达Cas9和sgRNA的细胞株,进行环状双侧同源臂供体介导的基因敲入。结果使用策略2、3和4均成功构建了携带EGFP的HSV-2,其中策略2的基因敲入效率最高,然后依次为策略3、策略4,策略1未观察到重组病毒的产生。蚀斑纯化后的重组病毒在7代内能稳定表达绿色荧光蛋白,并且和亲本株在Vero细胞上具有相似的生长特性。结论线性化单侧同源臂供体介导的基因敲入效率更高,敲除载体的稳转细胞株能够有效地提高同源重组修复机制介导的基因敲入效率。 Objective To construct a recombinant herpes simplex virus 2(HSV-2)expressing enhanced green fluorescent protein(EGFP)using clustered,regularly interspaced,short palindromic repeat/CRISPR-associated nuclease 9(CRISPR/Cas9)technology.Methods Four strategies for inserting exogenous EGFP gene into HSV-2 genome using CRISPR/Cas9 technology were designed:(1)conventional homology-directed repair:circular two homology arm donor-mediated gene knock-in;(2)linearized single homology arm donor-mediated gene knock-in;(3)homology-independent targeted integration;(4)conventional homology-directed repair-mediated by cell lines stably expressing Cas9 and sgRNA.Results The recombinant virus HSV-2-EGFP was successfully constructed based on the second,the third and the fourth strategies.The second strategy was the most efficient,followed by the third and the fourth strategies.The purified recombinant virus could stably express green fluorescent protein in seven passages and shared similar growth characteristics in Vero cells to the parental virus.Conclusions Linearized single homology arm donor could increase the efficiency of gene knock-in,and cell lines stably expressing Cas9 and sgRNA could increase the efficiency of gene knock-in mediated by homology-directed repair.
作者 苏文浩 任秀秀 赵婷婷 王轶男 李实实 黄秋芳 王晓杰 张晓焕 卫江波 Su Wenhao;Ren Xiuxiu;Zhao Tingting;Wang Yinan;Li Shishi;Huang Qiufang;Wang Xiaojie;Zhang Xiaohuan;Wei Jiangbo(Laboratory of Herpes Virus,National Vaccine and Serum Institute,Beijing 101111,China)
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2022年第5期369-375,共7页 Chinese Journal of Microbiology and Immunology
关键词 CRISPR/Cas9 单纯疱疹病毒2型 非同源末端连接 同源重组 CRISPR/Cas9 Herpes simplex virus 2 Nonhomologous end-joining Homology-directed repair
  • 相关文献

参考文献4

二级参考文献41

  • 1Manservigi R,Argnani R, Marconi P.HSV Recombinant Vectors for Gene Therapy.Open Virol. 2010;4:123-156.
  • 2Marconi P, Argnani R,Epstein AL,et aI.HSV as a vector in vaccine development and gene therapy.Adv Exp Med Biol. 2009;655: 118-144.
  • 3Marconi P, Argnani R,Berto E,et aI.HSV as a vector in vaccine development and gene therapy.Hum Vaccin.2008;4(2):91-105.
  • 4Frampton AR Jr, Goins WF, Nakano K, et aI.HSV trafficking and development of gene therapy vectors with applications in the nervous system.Gene Ther. 2005; 12(11 ):891-901.
  • 5Badin RA,Modo M,Cheetham M,et al~Protective effect of post-ischaemic viral delivery of heat shock proteins in vivo.J Cereb Blood Flow Metab.2009;29(2):254-263.
  • 6Tanaka M,Kagawa H,Yamanashi Y, et aI.Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo.J Virol. 2003:77(27:1382-1391.
  • 7Gierasch WW,Zimmerman DL,Ward SL,et aI.Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS. J Virol Methods.2006; 135(2): 197-206.
  • 8Kuroda T, Martuza RL,Todo T, et aI.Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.BMC Biotechnol.2006;6:40.
  • 9erada K,Wakimoto H,Tyminski E,et aI.Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.Gene Ther. 2006; 13(8):705-714.
  • 10Jeyaretna DS, Kuroda T.Recent advances in the development of oncolytic HSV-1 vectors: 'arming' of HSV-1 vectors and application of bacterial artificial chromosome technology for their construction. Curr Opin Mol Ther. 2007;9(5):447-466.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部